Dr. Christine Cadiz is a pharmacist who is specialized in Pharmacotherapy in Escondido, California. Patients can reach her at 2185 Citracado Pkwy, Pharmacy Department, Escondido or contact her on 442-281-1302. Active license number of Dr. Christine Cadiz is 67377 for Pharmacotherapy in California. Dr. Christine Cadiz is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Christine Cadiz speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Christine Cadiz are as mentioned below.
NPI Number:
1467832840
NPI Enumeration Date:
01 Jun, 2015
NPI Last Update On:
01 Jun, 2015
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Christine Cadiz are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
67377
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2185 Citracado Pkwy, Pharmacy Department Escondido, California
Zip:
92029-4159
Phone Number:
442-281-1302
Fax Number:
--
Patients can reach Dr. Christine Cadiz at 2185 Citracado Pkwy, Pharmacy Department, Escondido, California or can call on phone at 442-281-1302.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.